Pall Life Sciences' ForteBio Unveils Dip and Read Anti-Human Fab-CH1 Biosensor
January 09, 2013 at 17:05 PM EST
ForteBio, a division of Pall Life Sciences and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of its Dip and Read Anti-Human Fab-CH1 biosensor. The new biosensor enables an easy and rapid method for quantitation and kinetic characterization of human Fab, F(ab')2 and IgG